Park National Trimmed By $656,915 Its Pfizer (PFE) Holding; 11 Bullish Analysts Covering Lear (LEA)

Among 20 analysts covering Lear Corporation (NYSE:LEA), 11 have Buy rating, 2 Sell and 7 Hold. Therefore 55% are positive. Lear Corporation has $242.0 highest and $111 lowest target. $185.78’s average target is -0.57% below currents $186.84 stock price. Lear Corporation had 72 analyst reports since July 27, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, April 28 by RBC Capital Markets. The firm has “Neutral” rating by Robert W. Baird given on Tuesday, October 11. The stock of Lear Corporation (NYSE:LEA) has “Sell” rating given on Thursday, October 6 by Goldman Sachs. UBS downgraded the stock to “Neutral” rating in Tuesday, October 3 report. The company was upgraded on Wednesday, February 7 by Deutsche Bank. The company was upgraded on Friday, May 5 by Seaport Global. The stock of Lear Corporation (NYSE:LEA) has “Outperform” rating given on Monday, October 26 by RBC Capital Markets. The rating was maintained by RBC Capital Markets on Sunday, August 27 with “Hold”. On Friday, October 13 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. As per Wednesday, February 14, the company rating was maintained by Citigroup. See Lear Corporation (NYSE:LEA) latest ratings:

14/02/2018 Broker: Citigroup Rating: Buy New Target: $234.0 Maintain
07/02/2018 Broker: Deutsche Bank Rating: Buy New Target: $242.0 Upgrade
30/01/2018 Broker: Goldman Sachs Rating: Hold New Target: $187.0 Upgrade
29/01/2018 Broker: Guggenheim Rating: Hold New Target: $206.0 Maintain
29/01/2018 Broker: Jefferies Rating: Buy New Target: $231.0 Maintain
26/01/2018 Broker: Cowen & Co Rating: Buy New Target: $215.0 Maintain
23/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $212.0 Maintain
18/01/2018 Broker: Cowen & Co Rating: Buy New Target: $220.0 Maintain
08/01/2018 Broker: Guggenheim Rating: Hold New Target: $192.0 Maintain
05/01/2018 Broker: Longbow Rating: Buy New Target: $225 Initiates Coverage On

Park National Corp decreased Pfizer Inc (PFE) stake by 5.87% reported in 2017Q3 SEC filing. Park National Corp sold 18,769 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Park National Corp holds 301,169 shares with $10.75M value, down from 319,938 last quarter. Pfizer Inc now has $213.59B valuation. The stock decreased 0.66% or $0.24 during the last trading session, reaching $35.88. About 17.08M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since March 7, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Investors sentiment increased to 1.06 in Q3 2017. Its up 0.10, from 0.96 in 2017Q2. It is positive, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Ig Investment Mgmt invested in 2.19% or 11.98 million shares. Kames Pcl holds 765,654 shares or 0.75% of its portfolio. Apg Asset Mgmt Nv holds 0.69% or 11.66M shares in its portfolio. Outfitter Advsrs, a Virginia-based fund reported 7,530 shares. Bremer Tru Natl Association reported 39,933 shares stake. Parametrica Mgmt Ltd owns 0.18% invested in Pfizer Inc. (NYSE:PFE) for 11,755 shares. M Kraus And accumulated 21,113 shares. Greenleaf Tru holds 0.16% or 202,658 shares. Argi Investment Service Ltd Limited Liability Company accumulated 48,779 shares. Veritas Investment (Uk) Limited stated it has 0.05% in Pfizer Inc. (NYSE:PFE). Pure Financial Advsr accumulated 23,024 shares. Moreover, Ipswich Investment Mngmt Co has 0.54% invested in Pfizer Inc. (NYSE:PFE) for 33,794 shares. Seaward Mngmt Lp reported 1.13M shares. Altavista Wealth Management Incorporated has invested 0.77% of its portfolio in Pfizer Inc. (NYSE:PFE). Ironsides Asset Advisors Ltd has 0.53% invested in Pfizer Inc. (NYSE:PFE) for 36,035 shares.

Since September 12, 2017, it had 0 insider buys, and 7 selling transactions for $5.93 million activity. 9,510 Pfizer Inc. (NYSE:PFE) shares with value of $353,677 were sold by LUND-JURGENSEN KIRSTEN. Another trade for 38,230 shares valued at $1.34M was made by SUSMAN SALLY on Tuesday, September 12. $296,560 worth of Pfizer Inc. (NYSE:PFE) was sold by JOHNSON RADY A. The insider MACKENZIE ALEXANDER R sold 6,750 shares worth $249,750. Shares for $2.39 million were sold by Dolsten Mikael on Monday, February 26. On Monday, February 26 the insider CORNWELL W DON sold $64,679.

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer has $54.0 highest and $33.0 lowest target. $39.80’s average target is 10.93% above currents $35.88 stock price. Pfizer had 75 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Sell” rating by Citigroup on Tuesday, May 16. Jefferies maintained it with “Hold” rating and $39.0 target in Monday, February 26 report. Leerink Swann maintained the stock with “Market Perform” rating in Wednesday, January 31 report. The firm has “Market Perform” rating given on Wednesday, November 2 by BMO Capital Markets. The stock of Pfizer Inc. (NYSE:PFE) earned “Overweight” rating by Morgan Stanley on Wednesday, September 20. Jefferies maintained Pfizer Inc. (NYSE:PFE) rating on Thursday, August 4. Jefferies has “Buy” rating and $40 target. On Tuesday, November 21 the stock rating was maintained by BMO Capital Markets with “Buy”. S&P Research maintained Pfizer Inc. (NYSE:PFE) rating on Wednesday, October 28. S&P Research has “Hold” rating and $40 target. As per Tuesday, December 1, the company rating was initiated by Barclays Capital. The rating was downgraded by Jefferies to “Hold” on Thursday, October 13.

Park National Corp increased Cintas Corporation (NASDAQ:CTAS) stake by 5,800 shares to 8,912 valued at $1.29 million in 2017Q3. It also upped Bank Of New York Mellon Corp (NYSE:BK) stake by 39,224 shares and now owns 271,054 shares. At&T Inc (NYSE:T) was raised too.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1. They expect $0.70 EPS, up 1.45% or $0.01 from last year’s $0.69 per share. PFE’s profit will be $4.17B for 12.81 P/E if the $0.70 EPS becomes a reality. After $0.62 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 12.90% EPS growth.

Since September 18, 2017, it had 0 insider buys, and 13 selling transactions for $47.64 million activity. STEPHENS MEL sold $416,802 worth of Lear Corporation (NYSE:LEA) on Friday, September 22. Another trade for 6,694 shares valued at $1.27 million was sold by Kunkel Jay K.. Another trade for 22,756 shares valued at $4.33M was made by Larkin Terrence B on Friday, February 16. WALLACE HENRY D G also sold $690,025 worth of Lear Corporation (NYSE:LEA) shares. Simoncini Matthew also sold $19.01M worth of Lear Corporation (NYSE:LEA) shares. DiDonato Thomas A sold 21,415 shares worth $4.07M. Shares for $4.86M were sold by SCOTT RAYMOND E on Friday, February 16.

Lear Corporation designs, develops, engineers, makes, assembles, and supplies automotive seating, electrical distribution systems, and related components primarily to automotive original equipment manufacturers worldwide. The company has market cap of $12.50 billion. It operates in two divisions, Seating and E-Systems. It has a 10.05 P/E ratio. The Seating segment provides seat systems and related components, including leather and fabric products, seat trim covers, recliner mechanisms, seat tracks, seat structures and mechanisms, seat foams, and headrests primarily for automobiles and light trucks, compact cars, and sport utility vehicles, as well as thermoelectric seat heating and cooling systems.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.04, from 0.92 in 2017Q2. It improved, as 41 investors sold Lear Corporation shares while 173 reduced holdings. 61 funds opened positions while 135 raised stakes. 59.92 million shares or 4.64% less from 62.83 million shares in 2017Q2 were reported. Ameriprise Finance Inc invested in 52,261 shares or 0% of the stock. Oppenheimer & holds 0.01% or 3,061 shares in its portfolio. Pettee Investors holds 0.63% or 5,668 shares. Us National Bank De reported 0.01% of its portfolio in Lear Corporation (NYSE:LEA). Boston Prtnrs invested in 1.17 million shares or 0.25% of the stock. Vigilant Cap Mgmt Ltd Llc stated it has 350 shares. Cadence Capital Mngmt Ltd, Massachusetts-based fund reported 13,141 shares. Magnetar Fin accumulated 2,286 shares. Citadel Advisors Ltd Limited Liability Company owns 672,930 shares. California State Teachers Retirement Sys holds 0.04% or 115,050 shares in its portfolio. Asset Mgmt One accumulated 112,643 shares or 0.05% of the stock. Bnp Paribas Arbitrage holds 0.04% or 98,078 shares in its portfolio. Putnam Investments Ltd Llc invested 0.08% in Lear Corporation (NYSE:LEA). Jaffetilchin Invest Prns Ltd Co holds 11,246 shares. Wolverine Asset Mgmt Llc accumulated 20,165 shares.

The stock increased 1.51% or $2.78 during the last trading session, reaching $186.84. About 569,616 shares traded. Lear Corporation (NYSE:LEA) has risen 28.33% since March 7, 2017 and is uptrending. It has outperformed by 11.63% the S&P500.